BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 15728300)

  • 1. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
    Cocho D; Belvís R; Martí-Fàbregas J; Molina-Porcel L; Díaz-Manera J; Aleu A; Pagonabarraga J; García-Bargo D; Mauri A; Martí-Vilalta JL
    Neurology; 2005 Feb; 64(4):719-20. PubMed ID: 15728300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why are eligible thrombolysis candidates left untreated?
    Hills NK; Johnston SC
    Am J Prev Med; 2006 Dec; 31(6 Suppl 2):S210-6. PubMed ID: 17178305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke.
    California Acute Stroke Pilot Registry (CASPR) Investigators
    Neurology; 2005 Feb; 64(4):654-9. PubMed ID: 15728287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient ischemic attack after tissue plasminogen activator: aborted stroke or unnecessary stroke therapy?
    Uchino K; Massaro L; Hammer MD
    Cerebrovasc Dis; 2010; 29(1):57-61. PubMed ID: 19893313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of nonischemic stroke mimics among 411 code strokes at the University of California, San Diego, Stroke Center.
    Hemmen TM; Meyer BC; McClean TL; Lyden PD
    J Stroke Cerebrovasc Dis; 2008; 17(1):23-5. PubMed ID: 18190817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.
    Kahn JH; Viereck J; Kase C; Jeerakathil T; Romero R; Mehta SD; Kociol R; Babikian V
    J Emerg Med; 2005 Oct; 29(3):273-7. PubMed ID: 16183445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
    Vaishnav AG; Pettigrew LC; Ryan S
    Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency department evaluation of ischemic stroke and TIA: the BASIC Project.
    Brown DL; Lisabeth LD; Garcia NM; Smith MA; Morgenstern LB
    Neurology; 2004 Dec; 63(12):2250-4. PubMed ID: 15623682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma.
    Hsieh HC; Chen CH
    Clin Neurol Neurosurg; 2009 Jul; 111(6):562-3. PubMed ID: 19200644
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intravenous thrombolytic therapy: ideal treatment for acute ischemic stroke].
    Kappelle LJ; van der Worp HB
    Ned Tijdschr Geneeskd; 2000 May; 144(22):1025-8. PubMed ID: 10850102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombolytic therapy in acute ischemic stroke: present and future].
    Mori E
    No Shinkei Geka; 2003 Mar; 31(3):249-60. PubMed ID: 12684978
    [No Abstract]   [Full Text] [Related]  

  • 16. Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided.
    Boode B; Welzen V; Franke C; van Oostenbrugge R
    Cerebrovasc Dis; 2007; 23(4):294-8. PubMed ID: 17199087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of applied cases of thrombolytic therapy against ultra-acute ischemic stroke. Using the Japanese Standard Stroke Registry Database.
    Shiotsuki H; Ogushi Y; Fushimi K; Kobayashi S;
    Tokai J Exp Clin Med; 2005 Apr; 30(1):49-62. PubMed ID: 15952299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicine. Stroke--tPA and the clinic.
    Marler JR; Goldstein LB
    Science; 2003 Sep; 301(5640):1677. PubMed ID: 14500967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why ischemic stroke patients do not receive thrombolytic treatment: results from a general hospital.
    van den Berg JS; de Jong G
    Acta Neurol Scand; 2009 Sep; 120(3):157-60. PubMed ID: 19719807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of barriers to thrombolytic therapy: implications for nursing care in the emergency department.
    Johnson M; Bakas T
    J Neurosci Nurs; 2010 Apr; 42(2):88-94. PubMed ID: 20422794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.